Breast MR Imaging: Current Indications and Advanced Imaging Techniques

Radiologic Clinics of North America

Volumn 48, Issue 5, 2010, Pages 1013-1042

  Weinstein, Susan ^a   Rosen, Mark ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Breast cancer; Diffusion; Magnetic resonance imaging; Spectroscopy

Indexed keywords

ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; BRCA2 PROTEIN; GADOLINIUM; CONTRAST MEDIUM;

AXILLARY LYMPH NODE; BODY POSTURE; BREAST BIOPSY; BREAST CANCER; BREAST DISCHARGE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DIFFUSION WEIGHTED IMAGING; FOLLOW UP; GALACTOGRAPHY; GENE MUTATION; GLOMERULUS FILTRATION RATE; HIGH RISK PATIENT; HUMAN; IMAGE QUALITY; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; MASTECTOMY; MULTIPLE CANCER; NEPHROGENIC SYSTEMIC FIBROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OCCULT CANCER; PARTIAL MASTECTOMY; PATIENT POSITIONING; PECTORAL MUSCLE; PREOPERATIVE EVALUATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; SIGNAL NOISE RATIO; THORAX WALL CANCER; TUMOR VOLUME; VOXEL BASED MORPHOMETRY; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; COMPUTER ASSISTED DIAGNOSIS; COMPUTER PROGRAM; DIAGNOSTIC IMAGING; DIAGNOSTIC USE; ECHOMAMMOGRAPHY; FEMALE; FORECASTING; IMAGE SUBTRACTION; MASS SCREENING; PATHOLOGY; PROCEDURES; TRENDS;

BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CONTRAST MEDIA; DIAGNOSTIC IMAGING; FEMALE; FORECASTING; GADOLINIUM; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MAMMOGRAPHY; MASS SCREENING; SOFTWARE; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY, MAMMARY;

EID: 77956910994     PISSN: 00338389     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rcl.2010.06.011     Document Type: Review

References (162)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Kerlikowske K., Carney P.A., Geller B., et al. Performance of screening mammography among women with and without a first-degree relative with breast cancer. Ann Intern Med 2000, 133(11):855-863.
3. Kriege M., Brekelmans C.T., Boetes C., et al. Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition. N Engl J Med 2004, 351(5):427-437.
4. Mandelson M.T., Oestreicher N., Porter P.L., et al. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000, 92(13):1081-1087.
5. Kuhl C.K. The " coming of age" of nonmammographic screening for breast cancer. JAMA 2008, 299(18):2203-2205.
6. Kaiser W.A., Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Preliminary observations. Radiology 1989, 170(3 Pt 1):681-686.
7. Heywang S.H., Wolf A., Pruss E., et al. MR imaging of the breast with Gd-DTPA: use and limitations. Radiology 1989, 171(1):95-103.
8. Kuhl C.K., Bieling H.B., Gieseke J., et al. Healthy premenopausal breast parenchyma in dynamic contrast-enhanced MR imaging of the breast: normal contrast medium enhancement and cyclical-phase dependency. Radiology 1997, 203(1):137-144.
9. Saslow D., Boetes C., Burke W., et al. American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 2007, 57(2):75-89.
10. Bluemke D.A., Gatsonis C.A., Chen M.H., et al. Magnetic resonance imaging of the breast prior to biopsy. JAMA 2004, 292(22):2735-2742.
11. Orel S.G., Schnall M.D. MR imaging of the breast for the detection, diagnosis, and staging of breast cancer. Radiology 2001, 220(1):13-30.
12. Boetes C., Barentsz J.O., Mus R.D., et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced TurboFLASH subtraction technique. Radiology 1994, 193(3):777-781.
13. Fischer U., Kopka L., Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999, 213(3):881-888.
14. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 2005, 365(9473):1769-1778.
15. Kuhl C.K., Schmutzler R.K., Leutner C.C., et al. Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results. Radiology 2000, 215(1):267-279.
16. Warner E., Plewes D.B., Hill K.A., et al. Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination. JAMA 2004, 292(11):1317-1325.
17. Podo F., Sardanelli F., Canese R., et al. The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res 2002, 21(Suppl 3):115-124.
18. Tilanus-Linthorst M.M., Obdeijn I.M., Bartels K.C., et al. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000, 63(1):53-60.
19. Morris E.A., Liberman L., Ballon D.J., et al. MRI of occult breast carcinoma in a high-risk population. AJR Am J Roentgenol 2003, 181(3):619-626.
20. Lehman C.D., Blume J.D., Weatherall P., et al. Screening women at high risk for breast cancer with mammography and magnetic resonance imaging. Cancer 2005, 103(9):1898-1905.
21. Lehman C.D., Isaacs C., Schnall M.D., et al. Cancer yield of mammography, MR, and US in high-risk women: prospective multi-institution breast cancer screening study. Radiology 2007, 244(2):381-388.
22. Orel S.G., Mendonca M.H., Reynolds C., et al. MR imaging of ductal carcinoma in situ. Radiology 1997, 202(2):413-420.
23. Boetes C., Mann R.M. Ductal carcinoma in situ and breast MRI. Lancet 2007, 370(9586):459-460.
24. Bazzocchi M., Zuiani C., Panizza P., et al. Contrast-enhanced breast MRI in patients with suspicious microcalcifications on mammography: results of a multicenter trial. AJR Am J Roentgenol 2006, 186(6):1723-1732.
25. Ikeda O., Nishimura R., Miyayama H., et al. Magnetic resonance evaluation of the presence of an extensive intraductal component in breast cancer. Acta Radiol 2004, 45(7):721-725.
26. Menell J.H., Morris E.A., Dershaw D.D., et al. Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging. Breast J 2005, 11(6):382-390.
27. Neubauer H., Li M., Kuehne-Heid R., et al. High grade and non-high grade ductal carcinoma in situ on dynamic MR mammography: characteristic findings for signal increase and morphological pattern of enhancement. Br J Radiol 2003, 76(901):3-12.
28. Kuhl C.K., Schrading S., Bieling H.B., et al. MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study. Lancet 2007, 370(9586):485-492.
29. Partridge S.C. Future applications and innovations of clinical breast magnetic resonance imaging. Top Magn Reson Imaging 2008, 19(3):171-176.
30. Ikeda T., Monzawa S., Komoto K., et al. Performance assessment of phased-array coil in breast MR imaging. Magn Reson Med Sci 2004, 3(1):39-43.
31. Konyer N.B., Ramsay E.A., Bronskill M.J., et al. Comparison of MR imaging breast coils. Radiology 2002, 222(3):830-834.
32. Han M., Beatty P.J., Daniel B.L., et al. Independent slab-phase modulation combined with parallel imaging in bilateral breast MRI. Magn Reson Med 2009, 62(5):1221-1231.
33. Orlacchio A., Bolacchi F., Rotili A., et al. MR breast imaging: a comparative analysis of conventional and parallel imaging acquisition. Radiol Med 2008, 113(4):465-476.
34. Dougherty L., Isaac G., Rosen M.A., et al. High frame-rate simultaneous bilateral breast DCE-MRI. Magn Reson Med 2007, 57(1):220-225.
35. Calabrese M., Brizzi D., Carbonaro L., et al. Contrast-enhanced breast MR imaging of claustrophobic or oversized patients using an open low-field magnet. Radiol Med 2009, 114(2):267-285.
36. Rubinstein W.S., Latimer J.J., Sumkin J.H., et al. Prospective screening study of 0.5 Tesla dedicated magnetic resonance imaging for the detection of breast cancer in young, high-risk women. BMC Womens Health 2006, 6:10.
37. Paakko E., Reinikainen H., Lindholm E.L., et al. Low-field versus high-field MRI in diagnosing breast disorders. Eur Radiol 2005, 15(7):1361-1368.
38. Daniel B.L., Butts K., Glover G.H., et al. Breast cancer: gadolinium-enhanced MR imaging with a 0.5-T open imager and three-point Dixon technique. Radiology 1998, 207(1):183-190.
39. Pinker K., Grabner G., Bogner W., et al. A combined high temporal and high spatial resolution 3 Tesla MR imaging protocol for the assessment of breast lesions: initial results. Invest Radiol 2009, 44(9):553-558.
40. Matsuoka A., Minato M., Harada M., et al. Comparison of 3.0-and 1.5-tesla diffusion-weighted imaging in the visibility of breast cancer. Radiat Med 2008, 26(1):15-20.
41. Kuhl C.K. Breast MR imaging at 3T. Magn Reson Imaging Clin N Am 2007, 15(3):315-320. vi.
42. Kuhl C.K., Jost P., Morakkabati N., et al. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 2006, 239(3):666-676.
43. Available at:, Accessed October 3, 2010. http://www.acr.org/SecondaryMainMenuCategories/quality_safety/guidelines/breast/mri_breast.aspx.
44. Ballesio L., Savelli S., Angeletti M., et al. Breast MRI: are T2 IR sequences useful in the evaluation of breast lesions?. Eur J Radiol 2009, 71(1):96-101.
45. Kuhl C.K., Klaschik S., Mielcarek P., et al. Do T2-weighted pulse sequences help with the differential diagnosis of enhancing lesions in dynamic breast MRI?. J Magn Reson Imaging 1999, 9(2):187-196.
46. Taboada J.L., Stephens T.W., Krishnamurthy S., et al. The many faces of fat necrosis in the breast. AJR Am J Roentgenol 2009, 192(3):815-825.
47. Daly C.P., Jaeger B., Sill D.S. Variable appearances of fat necrosis on breast MRI. AJR Am J Roentgenol 2008, 191(5):1374-1380.
48. Testempassi E., Ishi C., Yamada T., et al. Case report: breast hamartoma: MR findings. Radiat Med 1995, 13(4):187-189.
49. Killian J.K., Merino M., Bondy C., et al. MRI of angiolipoma of the breast in Turner's syndrome. AJR Am J Roentgenol 2004, 183(6):1843-1844.
50. Available at:, Accessed October 3, 2010. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108919.htm.
51. Grobner T., Prischl F.C. Gadolinium and nephrogenic systemic fibrosis. Kidney Int 2007, 72(3):260-264.
52. Grobner T. Gadolinium-a specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis?. Nephrol Dial Transplant 2006, 21(4):1104-1108.
53. Kuhl C.K., Kooijman H., Gieseke J., et al. Effect of B1 inhomogeneity on breast MR imaging at 3.0 T. Radiology 2007, 244(3):929-930.
54. Stack J.P., Redmond O.M., Codd M.B., et al. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990, 174(2):491-494.
55. El Khouli R.H., Macura K.J., Barker P.B., et al. Relationship of temporal resolution to diagnostic performance for dynamic contrast enhanced MRI of the breast. J Magn Reson Imaging 2009, 30(5):999-1004.
56. Li X., Huang W., Yankeelov T.E., et al. Shutter-speed analysis of contrast reagent bolus-tracking data: preliminary observations in benign and malignant breast disease. Magn Reson Med 2005, 53(3):724-729.
57. Huang W., Li X., Morris E.A., et al. The magnetic resonance shutter speed discriminates vascular properties of malignant and benign breast tumors in vivo. Proc Natl Acad Sci U S A 2008, 105(46):17943-17948.
58. Nunes L.W., Schnall M.D., Orel S.G., et al. Breast MR imaging: interpretation model. Radiology 1997, 202(3):833-841.
59. Nunes L.W., Schnall M.D., Orel S.G. Update of breast MR imaging architectural interpretation model. Radiology 2001, 219(2):484-494.
60. Kuhl C.K., Mielcareck P., Klaschik S., et al. Dynamic breast MR imaging: are signal intensity time course data useful for differential diagnosis of enhancing lesions?. Radiology 1999, 211(1):101-110.
61. Kuhl C.K., Schild H.H., Morakkabati N. Dynamic bilateral contrast-enhanced MR imaging of the breast: trade-off between spatial and temporal resolution. Radiology 2005, 236(3):789-800.
62. Schnall M.D., Blume J., Bluemke D.A., et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006, 238(1):42-53.
63. Korosec F.R., Frayne R., Grist T.M., et al. Time-resolved contrast-enhanced 3D MR angiography. Magn Reson Med 1996, 36(3):345-351.
64. Perman W.H., Heiberg E.V., Herrmann V.M. Half-Fourier, three-dimensional technique for dynamic contrast-enhanced MR imaging of both breasts and axillae: initial characterization of breast lesions. Radiology 1996, 200(1):263-269.
65. Plewes D.B., Bishop J., Soutar I., et al. Errors in quantitative dynamic three-dimensional keyhole MR imaging of the breast. J Magn Reson Imaging 1995, 5(3):361-364.
66. Bishop J.E., Santyr G.E., Kelcz F., et al. Limitations of the keyhole technique for quantitative dynamic contrast-enhanced breast MRI. J Magn Reson Imaging 1997, 7(4):716-723.
67. Han M., Daniel B.L., Hargreaves B.A. Accelerated bilateral dynamic contrast-enhanced 3D spiral breast MRI using TSENSE. J Magn Reson Imaging 2008, 28(6):1425-1434.
68. Chan R.W., Ramsay E.A., Cunningham C.H., et al. Temporal stability of adaptive 3D radial MRI using multidimensional golden means. Magn Reson Med 2009, 61(2):354-363.
69. Baek H.M., Yu H.J., Chen J.H., et al. Quantitative correlation between (1)H MRS and dynamic contrast-enhanced MRI of human breast cancer. Magn Reson Imaging 2008, 26(4):523-531.
70. Jacobs M.A., Barker P.B., Argani P., et al. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging 2005, 21(1):23-28.
71. Kim J.K., Park S.H., Lee H.M., et al. In vivo 1H-MRS evaluation of malignant and benign breast diseases. Breast 2003, 12(3):179-182.
72. Kvistad K.A., Bakken I.J., Gribbestad I.S., et al. Characterization of neoplastic and normal human breast tissues with in vivo (1)H MR spectroscopy. J Magn Reson Imaging 1999, 10(2):159-164.
73. Gribbestad I.S., Singstad T.E., Nilsen G., et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging 1998, 8(6):1191-1197.
74. Roebuck J.R., Cecil K.M., Schnall M.D., et al. Human breast lesions: characterization with proton MR spectroscopy. Radiology 1998, 209(1):269-275.
75. Bartella L., Morris E.A., Dershaw D.D., et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study. Radiology 2006, 239(3):686-692.
76. Bartella L., Thakur S.B., Morris E.A., et al. Enhancing nonmass lesions in the breast: evaluation with proton (1H) MR spectroscopy. Radiology 2007, 245(1):80-87.
77. Chen J.H., Baek H.M., Nalcioglu O., et al. Estrogen receptor and breast MR imaging features: a correlation study. J Magn Reson Imaging 2008, 27(4):825-833.
78. Guo Y., Cai Y.Q., Cai Z.L., et al. Differentiation of clinically benign and malignant breast lesions using diffusion-weighted imaging. J Magn Reson Imaging 2002, 16(2):172-178.
79. Kinoshita T., Yashiro N., Ihara N., et al. Diffusion-weighted half-Fourier single-shot turbo spin echo imaging in breast tumors: differentiation of invasive ductal carcinoma from fibroadenoma. J Comput Assist Tomogr 2002, 26(6):1042-1046.
80. Kuroki Y., Nasu K., Kuroki S., et al. Diffusion-weighted imaging of breast cancer with the sensitivity encoding technique: analysis of the apparent diffusion coefficient value. Magn Reson Med Sci 2004, 3(2):79-85.
81. Partridge S.C., DeMartini W.B., Kurland B.F., et al. Quantitative diffusion-weighted imaging as an adjunct to conventional breast MRI for improved positive predictive value. AJR Am J Roentgenol 2009, 193(6):1716-1722.
82. Pereira F.P., Martins G., Figueiredo E., et al. Assessment of breast lesions with diffusion-weighted MRI: comparing the use of different b values. AJR Am J Roentgenol 2009, 193(4):1030-1035.
83. Lo G.G., Ai V., Chan J.K., et al. Diffusion-weighted magnetic resonance imaging of breast lesions: first experiences at 3 T. J Comput Assist Tomogr 2009, 33(1):63-69.
84. Bogner W., Gruber S., Pinker K., et al. Diffusion-weighted MR for differentiation of breast lesions at 3.0 T: how does selection of diffusion protocols affect diagnosis?. Radiology 2009, 253(2):341-351.
85. Wasif N., Garreau J., Terando A., et al. MRI versus ultrasonography and mammography for preoperative assessment of breast cancer. Am Surg 2009, 75(10):970-975.
86. Mann R.M., Veltman J., Barentsz J.O., et al. The value of MRI compared to mammography in the assessment of tumour extent in invasive lobular carcinoma of the breast. Eur J Surg Oncol 2008, 34(2):135-142.
87. Mann R.M., Loo C.E., Wobbes T., et al. The impact of preoperative breast MRI on the re-excision rate in invasive lobular carcinoma of the breast. Breast Cancer Res Treat 2010, 119(2):415-422.
88. Rosen P.P., Fracchia A.A., Urban J.A., et al. " Residual" mammary carcinoma following simulated partial mastectomy. Cancer 1975, 35(3):739-747.
89. Holland R., Veling S.H., Mravunac M., et al. Histologic multifocality of Tis, T1-2 breast carcinomas. Implications for clinical trials of breast-conserving surgery. Cancer 1985, 56(5):979-990.
90. Faverly D.R., Hendriks J.H., Holland R. Breast carcinomas of limited extent: frequency, radiologic-pathologic characteristics, and surgical margin requirements. Cancer 2001, 91(4):647-659.
91. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995, 333(22):1456-1461.
92. Veronesi U., Luini A., Galimberti V., et al. Conservation approaches for the management of stage I/II carcinoma of the breast: Milan Cancer Institute Trials. World J Surg 1994, 18(1):70-75.
93. Veronesi U., Luini A., Del Vecchio M., et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993, 328(22):1587-1591.
94. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 2002, 347(16):1233-1241.
95. Wapnir I.L., Anderson S.J., Mamounas E.P., et al. Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. J Clin Oncol 2006, 24(13):2028-2037.
96. Solin L.J., Orel S.G., Hwang W.T., et al. Relationship of breast magnetic resonance imaging to outcome after breast-conservation treatment with radiation for women with early-stage invasive breast carcinoma or ductal carcinoma in situ. J Clin Oncol 2008, 26(3):386-391.
97. Schnall M.D., Blume J., Bluemke D.A., et al. MRI detection of distinct incidental cancer in women with primary breast cancer studied in IBMC 6883. J Surg Oncol 2005, 92(1):32-38.
98. Deurloo E.E., Peterse J.L., Rutgers E.J., et al. Additional breast lesions in patients eligible for breast-conserving therapy by MRI: impact on preoperative management and potential benefit of computerised analysis. Eur J Cancer 2005, 41(10):1393-1401.
99. Schelfout K., Van Goethem M., Kersschot E., et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol 2004, 30(5):501-507.
100. Berg W.A., Gutierrez L., NessAiver M.S., et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004, 233(3):830-849.
101. Hata T., Takahashi H., Watanabe K., et al. Magnetic resonance imaging for preoperative evaluation of breast cancer: a comparative study with mammography and ultrasonography. J Am Coll Surg 2004, 198(2):190-197.
102. Sardanelli F., Giuseppetti G.M., Panizza P., et al. Sensitivity of MRI versus mammography for detecting foci of multifocal, multicentric breast cancer in fatty and dense breasts using the whole-breast pathologic examination as a gold standard. AJR Am J Roentgenol 2004, 183(4):1149-1157.
103. Orel S.G., Schnall M.D., Powell C.M., et al. Staging of suspected breast cancer: effect of MR imaging and MR-guided biopsy. Radiology 1995, 196(1):115-122.
104. Boetes C., Mus R.D., Holland R., et al. Breast tumors: comparative accuracy of MR imaging relative to mammography and US for demonstrating extent. Radiology 1995, 197(3):743-747.
105. Mumtaz H., Hall-Craggs M.A., Davidson T., et al. Staging of symptomatic primary breast cancer with MR imaging. AJR Am J Roentgenol 1997, 169(2):417-424.
106. Kramer S., Schulz-Wendtland R., Hagedorn K., et al. Magnetic resonance imaging and its role in the diagnosis of multicentric breast cancer. Anticancer Res 1998, 18(3C):2163-2164.
107. Bedrosian I., Mick R., Orel S.G., et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer 2003, 98(3):468-473.
108. Schnall M. MR imaging evaluation of cancer extent: is there clinical relevance?. Magn Reson Imaging Clin N Am 2006, 14(3):379-381. vii.
109. Morris E.A., Schwartz L.H., Drotman M.B., et al. Evaluation of pectoralis major muscle in patients with posterior breast tumors on breast MR images: early experience. Radiology 2000, 214(1):67-72.
110. Kazama T., Nakamura S., Doi O., et al. Prospective evaluation of pectoralis muscle invasion of breast cancer by MR imaging. Breast Cancer 2005, 12(4):312-316.
111. Egan R.L. Bilateral breast carcinomas: role of mammography. Cancer 1976, 38(2):931-938.
112. Hungness E.S., Safa M., Shaughnessy E.A., et al. Bilateral synchronous breast cancer: mode of detection and comparison of histologic features between the 2 breasts. Surgery 2000, 128(4):702-707.
113. Slanetz P.J., Edmister W.B., Yeh E.D., et al. Occult contralateral breast carcinoma incidentally detected by breast magnetic resonance imaging. Breast J 2002, 8(3):145-148.
114. Pediconi F., Catalano C., Roselli A., et al. Contrast-enhanced MR mammography for evaluation of the contralateral breast in patients with diagnosed unilateral breast cancer or high-risk lesions. Radiology 2007, 243(3):670-680.
115. Liberman L., Morris E.A., Kim C.M., et al. MR imaging findings in the contralateral breast of women with recently diagnosed breast cancer. AJR Am J Roentgenol 2003, 180(2):333-341.
116. Lee S.G., Orel S.G., Woo I.J., et al. MR imaging screening of the contralateral breast in patients with newly diagnosed breast cancer: preliminary results. Radiology 2003, 226(3):773-778.
117. Lehman C.D., Blume J.D., Thickman D., et al. Added cancer yield of MRI in screening the contralateral breast of women recently diagnosed with breast cancer: results from the International Breast Magnetic Resonance Consortium (IBMC) Trial. J Surg Oncol 2005, 92(1):9-15. [discussion: 15-6].
118. Lehman C.D., Gatsonis C., Kuhl C.K., et al. MRI evaluation of the contralateral breast in women with recently diagnosed breast cancer. N Engl J Med 2007, 356(13):1295-1303.
119. Morris E.A., Schwartz L.H., Dershaw D.D., et al. MR imaging of the breast in patients with occult primary breast carcinoma. Radiology 1997, 205(2):437-440.
120. Tilanus-Linthorst M.M., Obdeijn A.I., Bontenbal M., et al. MRI in patients with axillary metastases of occult breast carcinoma. Breast Cancer Res Treat 1997, 44(2):179-182.
121. Orel S.G., Weinstein S.P., Schnall M.D., et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology 1999, 212(2):543-549.
122. Stomper P.C., Waddell B.E., Edge S.B., et al. Breast MRI in the evaluation of patients with occult primary breast carcinoma. Breast J 1999, 5(4):230-234.
123. Henry-Tillman R.S., Harms S.E., Westbrook K.C., et al. Role of breast magnetic resonance imaging in determining breast as a source of unknown metastatic lymphadenopathy. Am J Surg 1999, 178(6):496-500.
124. Buchanan C.L., Morris E.A., Dorn P.L., et al. Utility of breast magnetic resonance imaging in patients with occult primary breast cancer. Ann Surg Oncol 2005, 12(12):1045-1053.
125. Tozaki M., Yamashiro N., Suzuki T., et al. MR-guided vacuum-assisted breast biopsy: is it an essential technique?. Breast Cancer 2009, 16(2):121-125.
126. Malhaire C., El Khoury C., Thibault F., et al. Vacuum-assisted biopsies under MR guidance: results of 72 procedures. Eur Radiol 2010, 20:1554-1562.
127. Masood S., Khalbuss W.E. Nipple fluid cytology. Clin Lab Med 2005, 25(4):787-794. vii-viii.
128. Rovno H.D., Siegelman E.S., Reynolds C., et al. Solitary intraductal papilloma: findings at MR imaging and MR galactography. AJR Am J Roentgenol 1999, 172(1):151-155.
129. Orel S.G., Dougherty C.S., Reynolds C., et al. MR imaging in patients with nipple discharge: initial experience. Radiology 2000, 216(1):248-254.
130. Nakahara H., Namba K., Watanabe R., et al. A comparison of MR imaging, galactography and ultrasonography in patients with nipple discharge. Breast Cancer 2003, 10(4):320-329.
131. Morrogh M., Morris E.A., Liberman L., et al. The predictive value of ductography and magnetic resonance imaging in the management of nipple discharge. Ann Surg Oncol 2007, 14(12):3369-3377.
132. Yoshimoto M., Kasumi F., Iwase T., et al. Magnetic resonance galactography for a patient with nipple discharge. Breast Cancer Res Treat 1997, 42(1):87-90.
133. Moy L., Elias K., Patel V., et al. Is breast MRI helpful in the evaluation of inconclusive mammographic findings?. AJR Am J Roentgenol 2009, 193(4):986-993.
134. Fisher B., Brown A., Mamounas E., et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997, 15(7):2483-2493.
135. Fisher B., Bryant J., Wolmark N., et al. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer. J Clin Oncol 1998, 16(8):2672-2685.
136. Chang Y.C., Huang C.S., Liu Y.J., et al. Angiogenic response of locally advanced breast cancer to neoadjuvant chemotherapy evaluated with parametric histogram from dynamic contrast-enhanced MRI. Phys Med Biol 2004, 49(16):3593-3602.
137. Martincich L., Montemurro F., De Rosa G., et al. Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004, 83(1):67-76.
138. Padhani A.R., Hayes C., Assersohn L., et al. Prediction of clinicopathologic response of breast cancer to primary chemotherapy at contrast-enhanced MR imaging: initial clinical results. Radiology 2006, 239(2):361-374.
139. Pickles M.D., Lowry M., Manton D.J., et al. Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Cancer Res Treat 2005, 91(1):1-10.
140. Esserman L., Hylton N., Yassa L., et al. Utility of magnetic resonance imaging in the management of breast cancer: evidence for improved preoperative staging. J Clin Oncol 1999, 17(1):110-119.
141. Drew P.J., Kerin M.J., Mahapatra T., et al. Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast. Eur J Surg Oncol 2001, 27(7):617-620.
142. Balu-Maestro C., Chapellier C., Bleuse A., et al. Imaging in evaluation of response to neoadjuvant breast cancer treatment benefits of MRI. Breast Cancer Res Treat 2002, 72(2):145-152.
143. Partridge S.C., Gibbs J.E., Lu Y., et al. Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy. AJR Am J Roentgenol 2002, 179(5):1193-1199.
144. Partridge S.C., Gibbs J.E., Lu Y., et al. MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005, 184(6):1774-1781.
145. Jagannathan N.R., Kumar M., Seenu V., et al. Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br J Cancer 2001, 84(8):1016-1022.
146. Meisamy S., Bolan P.J., Baker E.H., et al. Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy-a pilot study at 4 T. Radiology 2004, 233(2):424-431.
147. Baek H.M., Chen J.H., Nie K., et al. Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 2009, 251(3):653-662.
148. Ford D., Easton D.F., Bishop D.T., et al. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994, 343(8899):692-695.
149. Antoniou A., Pharoah P.D., Narod S., et al. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 2003, 72(5):1117-1130.
150. Kuhl C.K., Schrading S., Leutner C.C., et al. Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 2005, 23(33):8469-8476.
151. Weinstein S.P., Localio A.R., Conant E.F., et al. Multimodality screening of high-risk women: a prospective cohort study. J Clin Oncol 2009, 27:6124-6128.
152. Warren R.M., Pointon L., Thompson D., et al. Reading protocol for dynamic contrast-enhanced MR images of the breast: sensitivity and specificity analysis. Radiology 2005, 236(3):779-788.
153. Ikeda D.M., Hylton N.M., Kinkel K., et al. Development, standardization, and testing of a lexicon for reporting contrast-enhanced breast magnetic resonance imaging studies. J Magn Reson Imaging 2001, 13(6):889-895.
154. Berg W.A., Campassi C., Langenberg P., et al. Breast Imaging Reporting and Data System: inter- and intraobserver variability in feature analysis and final assessment. AJR Am J Roentgenol 2000, 174(6):1769-1777.
155. Warner E., Causer P.A. MRI surveillance for hereditary breast-cancer risk. Lancet 2005, 365(9473):1747-1749.
156. American College of Radiology ACR BI-RADS: ACR breast imaging reporting and data system, breast imaging atlas 2003, American College of Radiology, Reston (VA).
157. Qualheim R.E., Gall E.A. Breast carcinoma with multiple sites of origin. Cancer 1957, 10(3):460-468.
158. Smitt M.C., Nowels K.W., Zdeblick M.J., et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995, 76(2):259-267.
159. Katipamula R., Degnim A.C., Hoskin T., et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol 2009, 27(25):4082-4088.
160. Alderman A.K., Hawley S.T., Waljee J., et al. Understanding the impact of breast reconstruction on the surgical decision-making process for breast cancer. Cancer 2008, 112(3):489-494.
161. Turnbull L., Brown S., Harvey I., et al. Comparative effectiveness of MRI in breast cancer (COMICE) trial: a randomised controlled trial. Lancet 2010, 375(9714):563-571.
162. Fischer U., Zachariae O., Baum F., et al. The influence of preoperative MRI of the breasts on recurrence rate in patients with breast cancer. Eur Radiol 2004, 14(10):1725-1731.